Receptor mosaics of neural and immune communication: Possible implications for basal ganglia functions

Brain Research Reviews

Volumn 58, Issue 2, 2008, Pages 400-414

  Agnati, Luigi F ^a,b   Fuxe, Kjell G ^c   Goncharova, Larisa B ^d   Tarakanov, Alexander O ^e  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b IRCCS SAN CAMILLO HOSPITAL   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

^d City Diagnostic Center Virology   (Russian Federation)

^e ST PETERSBURG INSTITUTE FOR INFORMATICS AND AUTOMATION   (Russian Federation)

Author keywords

Basal ganglia; Receptor ensemble; Superfamily; Synapse

Indexed keywords

CYTOKINE; RECEPTOR;

BASAL GANGLION; CELL COMMUNICATION; HUMAN; IMMUNOCOMPETENT CELL; NERVE CELL; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE;

ANIMALS; BASAL GANGLIA; CELL COMMUNICATION; HUMANS; MODELS, NEUROLOGICAL; NEURONS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 42949143958     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2007.10.002     Document Type: Review

References (159)

1. Agnati L.F., Fuxe K., Zoli M., Rondanini C., and Ogren S.-O. New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram. Med. Biol. 60 (1982) 183-190
2. Agnati L.F., Celani M.F., and Fuxe K. Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites. Acta Physiol. Scand. 118 (1983) 79-81
3. Agnati L.F., Santarossa L., Benfenati F., Ferri M., Morpurgo A., Apolloni B., and Fuxe K. Molecular basis of learning and memory: modelling based on receptor mosaics. In: Apolloni B., and Kurfes F. (Eds). From Synapses to Rules (2002), Kluwer, New York 165-196
4. Agnati L.F., Ferre S., Lluis C., Franco R., and Fuxe K. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol. Rev. 55 3 (2003) 509-550
5. Agnati L.F., Ferre S., Leo G., Lluis C., Canela E.I., Franco R., and Fuxe K. On the molecular basis of the receptor mosaic hypothesis of the engram. J. Mol. Cell. Neurobiol. 24 (2004) 501-516
6. Agnati L.F., Tarakanov A.O., Ferre S., Fuxe K., and Guidolin D. Receptor-receptor interactions, receptor mosaics, and basic principles of molecular network organization: possible implication for drug development. J. Mol. Neurosci. 26 2-3 (2005) 193-208
7. Agnati L.F., Guidolin D., Genedani S., Ferre S., Bigiani A., Woods A.S., and Fuxe K. How proteins come together in the plasma membrane and function in macromolecular assemblies: focus on receptor mosaics. J. Mol. Neurosci. 26 (2005) 133-154
8. Aisen P.S., Marin D., Altstiel L., Goodwin C., Baruch B., Jacobson R., Ryan T., and Davis K.L. A pilot study of prednisone in Alzheimer's disease. Dementia 7 (1996) 201-206
9. Akira S., and Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4 (2004) 499-511
10. Alderton F., Rakhit S., Kong K.C., Plamer T., Sambi B., Pyne S., and Pyne N.J. Tethering of the platelet-derived growth factor receptor to G-protein-coupled receptors: a novel platform for integrative signaling by these receptor classes in mammalian cells. J. Biol. Chem. 276 30 (2001) 28578-28585
11. Allen S.J., Crown S.E., and Handel T.M. Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25 (2007) 787-820
12. Antonelli T., Tomasini M.C., Fuxe K., Agnati L.F., Tanganelli S., and Ferraro L. Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia. J. Neural Transm. 114 1 (2007) 105-113
13. Armant M.A., and Fenton M.J. Toll-like receptors: a family of pattern-recognition receptors in mammals. Genome Biol. 3 8 (2002) 3011-3016
14. Armstrong J.M., Chen J.F., Schwarzschild M.A., Apasov S., Smith P.T., Caldwell C., Chen P., Figler H., Sullivan G., Fink S., Linden J., and Sitkovsky M. Gene dose effect reveals no Gs-coupled A2A-receptor gene deficient mice. Biochem. J. 354 (2001) 123-130
15. Balabanian K., Lagane B., Infantino S., Chow K.Y., Harriague J., Moepps B., Arenzana-Seisdedos F., Thelen M., and Bachelerie F. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280 (2005) 35760-35766
16. Banisadr G., Skrzydelski D., Kitabgi P., Rostene W., and Parsadaniantz S.M. Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur. J. Neurosci. 18 (2003) 1593-1606
17. Banisadr G., Rostene W., Kitabgi P., and Parsadaniantz S.M. Chemokines and brain functions. Curr. Drug Targets Inflam. Allergy 4 (2005) 387-399
18. Banisadr, Gosselin R.D., Mechighel P., Kitabgi P., Rostene W., and Parsadaniantz S.M. Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J. Comp. Neurol. 489 (2005) 275-292
19. Barclay A. Membrane proteins with immunoglobuline-like domains-a master superfamily of interaction molecules. Semin. Immunol. 15 4 (2003) 215-223
20. Basu S., and Dasgupta P.S. Dopamine, a neurotransmitter, influences the immune system. J. Neuroimmunol. 102 (2000) 113-124
21. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 6934-6938
22. Bidlack J.M., Khimich M., Parkhill A.L., Sumagin S., Sun B., and Tipton C.M. Opioid receptors and signaling on cells from the immune system. J. Neuroimmune Pharmacol. 1 3 (2006) 260-269
23. Block M.L., Zecca L., and Hong J.-S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev., Neurosci. 8 (2007) 57-59
24. Bonavia R., Bajetto A., Barbero S., Pirani P., Florio T., and Schettini G. Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation. Toxicol. Lett. 139 (2003) 181-189
25. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat. Rev.. Neurosci. 2 (2001) 274-286
26. Brown S., Hu N., and Hombria J.C.-G. Novel level of signalling control in the JAK/STAT pathway revealed by in situ visualization of protein-protein interaction during Drosophila development. Development 130 (2003) 3077-3084
27. Callewaere C., Banisadr G., Rostene W., and Parsadaniantz S.M. Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulation. J. Mol. Endocrinol. 38 (2007) 355-363
28. Campana W.M., and Myers R.R. Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury. Eur. J. Neurosci. 18 (2003) 1497-1506
29. Chen C., Li J., Bot G., Szabo I., Rogers T.G., and Liu-Chen L.Y. Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur. J. Pharmacol. 483 (2004) 175-186
30. Chen J., Yu S., Conha Q., Zhu H., Mix Y., Winblad E., Ljunggren H., and Zhu J. Kainic acid-induced excitotoxic hippocampal neuro-degeneration in C57BL/6 mice: B cell and T cell subsets may contribute differently to the pathogenesis. Brain Behav. Immun. 18 (2004) 175-185
31. Cherry R.J., Wilson K.M., Triantafilou K., O'Toole P., Morrison I.E.G., Smith P.R., and Fernandez N. Detection of dimers of dimers of human leucocyte antigen (HLA)-DR on the surface of living cells by single-particle fluorescence imaging. J. Cell Biol. 140 1 (1998) 71-79
32. Cho C., and Miller R.J. Chemokine receptors and neural function. J. Neurovirology 8 (2002) 573-584
33. Cicchetti F., Brownell A.L., Williams K., Chen Y.I., Livni E., and Isacson O. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur. J. Neurosci. 15 (2002) 991-998
34. Collins F.S. Finishing the euchromatic sequence of the human genome. Nature 431 (2004) 931-945
35. Crawford G.D., Le W.D., Smith R.G., Xie W.J., Stefani E., and Appel S.H. A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J. Neurosci. 12 (1992) 3392-3398
36. De Mayer E., and Mayer-Guignard J. Type I interferons. Int. Rev. Immunol. 17 (1998) 53-73
37. Deleplanque B., Vitiello S., Le Moal M.L., and Neveu P.J. Modulation of immune reactivity by unilateral striatal and mesolimbic dopaminergic lesions. Neurosci. Lett. 166 (1994) 216-220
38. Delvin M.G., and Christopoulos A. Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum. J. Neurochem. 80 (2002) 1095-1102
39. Devoino L., Alperina E., Galkina O., and Ilyutchenok R. Involvement of brain dopaminergic structures in neuroimmunomodulation. Int. J. Neurosci. 91 (1997) 213-228
40. Devoino L.V., Alperina E.L., Gevorgyan M.M., and Cheido M.A. Involvement of dopamine D1 and D2 receptors in the rat nucleus accumbens in immunostimulation. Neurosci. Behav. Physiol. 37 2 (2007) 147-151
41. Dietrich A., and Mc Daniel W.F. Endocannabinoids and exercise. Br. J. Sports Med. 38 (2004) 536-541
42. Drews J. Genomic sciences and the medicine of tomorrow. Nat. Biotechnol. 14 (1996) 1516-1518
43. Drews J. Drug discovery: a historical perspective. Science 287 (2000) 1960-1964
44. Dustin M.L. Membrane domains and the immunological synapse: keeping T cells resting and ready. J. Clin. Invest. 109 (2002) 155-160
45. Dustin M.L., and Colman D.R. Neural and immunological synaptic relations. Science 298 (2002) 785-789
46. Elcock A.H., and McCammon J.A. Identification of protein oligomerization states by analysis of interface conservation. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2990-2994
47. English A. Cytokines, growth factors and sprouting at the neuromuscular junction. J. Neurocytol. 32 5-8 (2003) 943-960
48. Ferger B., Leng A., Mura A., Hengerer B., and Feldom J. Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum. J. Neurochem. 89 (2004) 822-833
49. Fernandez-Botran R., Chilton P.M., and Ma Y. Soluble cytokine receptors: their roles in immunoregulation, disease, and therapy. Adv. Immunol. 63 (1996) 269-336
50. Fernandez-Ruiz J., Lastres-Becker I., Cabranes A., Gonzales S., and Ramos J.A. Endocannabinoids and basal ganglia functionality. Prostaglandins Leukot. Essent. Fat. Acids 66 (2002) 257-267
51. Flower D.R. Modelling G-protein-coupled receptors for drug design. Biochim. Biophys. Acta 1422 (1999) 207-234
52. Franco R., Lluis C., Canela E.I., Mallol J., Agnati L., Casado V., Ciruela F., Ferre S., and Fuxe K. Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins. J. Neural Transm. 114 1 (2007) 93-104
53. Fuxe K., and Agnati L.F. Receptor-receptor interactions in the central nervous system. A new integrative mechanism in synapses. Med. Res. Rev. 5 (1985) 441-482
54. Fuxe K., Agnati L.F., Benfenati F., Cimino M., Algeri S., Hökfelt T., and Mutt V. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites. Acta Physiol. Scand. 113 (1981) 567-569
55. Fuxe K., Agnati L.F., Benfenati F., Celani M., Zini I., Zoli M., and Mutt V. Evidence for the existence of receptor-receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides. J. Neural Transm. Suppl. 18 (1983) 165-179
56. Fuxe K., Ferre S., Zoli M., and Agnati L.F. Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia. Brain Res. Rev. 26 (1998) 258-273
57. Fuxe K., Ferre S., Woods A., Rivera A., Hoistad M., Franco R., Kehr J., and Agnati L.F. Novel strategies for the treatment of Parkinson's disease. Focus on receptor-receptor interactions in the basal ganglia. In: Kehr J., Fuxe K., Ungerstedt U., and Svensson T. (Eds). Monitoring Molecules in Neuroscience (2003), Karolinska University Press, Stockholm, Sweden 199-202
58. Fuxe K., Ferre S., Canals M., Torvinen M., Terasmaa A., Marcellino D., Goldberg S.R., Staines W., Jacobsen K.X., Lluis C., Woods A.S., Agnati L.F., and Franco R. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. J. Mol. Neurosci. 26 2-3 (2005) 209-220
59. Fuxe K., Canals M., Torvinen M., Marcellino D., Terasmaa A., Genedani S., Leo G., Guidolin D., Diaz-Cabiale Z., Rivera A., Lundstrom L., Langel U., Narvaez J., Tanganelli S., Lluis C., Ferre S., Woods A., Franco R., and Agnati L.F. Intramembrane receptor-receptor interactions: a novel principle in molecular medicine. J. Neural Transm. 114 1 (2007) 49-75
60. Gao H.-M., Liu B., Zhang W., and Hong J.-S. Novel anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol. Sci. 24 (2003) 395-401
61. George S.R., Fan T., Xie Z., Tse R., Tam V., Varghese G., and O'Dowd B.F. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J. Biol. Chem. 275 (2000) 26128-26135
62. George S.R., O'Dowd B.F., and Lee S.P. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat. Rev. Drug Discov. 1 (2002) 808-820
63. Gestwicki J.E., and Kiessling L.L. Inter-receptor communication through arrays of bacterial chemoreceptors. Nature 415 (2002) 81-84
64. Giorelli M., Livrea P., and Trojano M. Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta. J. Interferon Cytokine Res. 25 7 (2005) 395-406
65. Gomes I., Jordan B.A., Gupta A., Trapaidze N., Nagy V., and Devi L.A. Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J. Neurosci. 20 (2000) RC110
66. Goncharova L.B., and Tarakanov A.O. Molecular networks of brain and immunity. Brain Res. Rev. 55 1 (2007) 155-166
67. Gordon J., and Barnes N.M. Lymphocytes transport serotonin and dopamine: agony or ecstasy?. Trends Immunol. 24 8 (2003) 438-443
68. Grewal R.P., Yoshida T., Finch C.E., and Morgan T.E. Scavenger receptor mRNAs in rat brain microglia are induced by kainic acid lesioning and by cytokines. NeuroReport 8 (1997) 1077-1081
69. Grilli M., Pizzi M., Mano M., and Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 22 (1996) 1383-1385
70. Guyon A., and Nahon J.-L. Multiple actions of the chemokine stromal cell-derived factor-1a on neuronal activity. J. Mol. Endocrinol. 38 (2007) 365-376
71. He L., Fong J., von Zastrow M., and Whistler J.L. Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108 (2002) 271-282
72. Hebert T.E., and Bouvier M. Structural and functional aspects of G protein-coupled receptor oligomerization. Biochem. Cell. Biol. 76 (1998) 1-11
73. Heldin C.H. Dimerization of cell surface receptors in signal transduction. Cell 80 (1995) 213-223
74. Hirono M., Yoshioka T., and Konishi S. GABAB receptor activation enhances mGluR-mediated responses at cerebellar excitatory synapses. Nat. Neurosci. 4 (2001) 1207-1216
75. Hirsch E.C., Hunot S., Damier P., and Faucheux B. Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?. Ann. Neurol. 44 3 Suppl. 1 (1998) S115-S120
76. Hirsch E.C., Hunot S., and Hartmann A. Neuroinflammatory processes in Parkinson's disease. Parkinsonism Relat. Disord. 11 Suppl. 1 (2005) S9-S15
77. Hirst R.A., Lambert D.G., and Notcutt W.G. Pharmacology and potential therapeutic uses of cannabis. Br. J. Anaesth. 81 (1998) 77-84
78. Hunot S., Brugg B., Ricard D., Michel P.P., Muriel M.-P., Ruberg M., Faucheux B.A., Agid Y., and Hirsch E.C. Nuclear translocation of NF-kB is increased in dopaminergic neurons of patients with Parkinson disease. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 7531-7536
79. Ilani T., Strous R.D., and Fuchs S. Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells. FASEB J. 18 (2004) 1600-1602
80. Janssen S., and Beyaert R. Role of toll-like receptors in pathogen recognition. Clin. Microbiol. Rev. 16 4 (2003) 637-646
81. Jordan B.A., and Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399 (1999) 697-700
82. Kearn C.S., Blake-Palmer K., Daniel E., Mackie K., and Glass M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?. Mol. Pharmacol. 67 5 (2005) 1697-1704
83. Kiessling L.L., Gestwicki J.E., and Strong L.E. Synthetic multivalent ligands as probes of signal transduction. Angew. Chem. Int. Ed. 45 (2006) 2348-2368
84. Lee M.S., and Kim Y.-J. Pattern-recognition receptor signaling initiated from extracellular, membrane, and cytoplasmic space. Mol. Cells 23 1 (2007) 1-10
85. Lee S.P., So C.H., Rashid A.J., Varghese G., Cheng R., Lanca A.J., O'Dowd B.F., and George S.R. Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J. Biol. Chem. 279 34 (2004) 35671-35678
86. Lefkowitz R.J., Cotecchia S., Samama P., and Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14 (1993) 303-307
87. Lefranc M.-P., Pommie C., Ruiz M., Giudicelli V., Foulquier E., Truong L., Thouvenin-Contet V., and Lefranc G. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev. Comp. Immunol. 27 (2003) 55-77
88. Lefranc M.-P., Pommie C., Kaas Q., Duprat E., Bosc N., Guiraudou D., Jean C., Ruiz M., Da Piedade I., Rouard M., Foulquier E., Thouvenin V., and Lefranc G. IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains. Dev. Comp. Immunol. 29 (2005) 185-203
89. Leshner A.I. Molecular mechanisms of cocaine addiction. N. Engl. J. Med. 335 2 (1996) 128-129
90. Levite M. Nerve driven immunity: the direct effects of neuro-transmitters on T-cell function. Ann. N.Y. Acad. Sci. 917 (2000) 307-321
91. Levite M. Autoimmune epilepsy. Nat. Immunol. 3 (2002) 500
92. Levite M., and Hart I. Immunotherapy for epilepsy. Expert Rev. Neurotherapeutics 2 6 (2002) 809-814
93. Levite M., Chowers Y., Ganor Y., Besser M., Hershkovits R., and Cahalon L. Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function. Eur. J. Immunol. 12 (2001) 3504-3512
94. Li F., Chong Z.Z., and Maiese K. Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways. NeuroSignals 13 (2004) 265-289
95. Liu F., Wan Q., Pristupa Z.B., Yu X.M., Wang Y.T., and Niznik H.B. Direct protein-protein coupling enables cross-talk between dopamine D5 and g-aminobutyric acid A receptors. Nature 403 (2000) 274-280
96. Lutskiy M.I., Beardsley D.S., Rosen F.S., and Remold-O'Donnell E. Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome. Blood 106 8 (2005) 2815-2817
97. Maggio R., Barbier P., Colelli A., Salvadori F., Demontis G., and Corsini G.U. G protein-linked receptors: pharmacological evidence for the formation of heterodimers. J. Pharmacol. Exp. Ther. 291 (1999) 251-257
98. Martino D., Church A., and Gavin Giovannoni G. Are antibasal ganglia antibodies important, and clinically useful?. Pract. Neurol. 7 (2007) 32-41
99. McGeer P.L., Itagaki S., and McGeer E.G. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol. 76 (1988) 550-557
100. McGeer P.L., Schulzer M., and McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47 (1996) 425-432
101. McKenna F., McLaughlin P.J., Lewis B.J., Sibbring G.C., Cummerson J.A., Bowen-Jones D., and Moots R.J. Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J. Neuroimmunol. 132 (2002) 34-40
102. Medzhitov R., and Janeway Jr. C.A. Decoding the patterns of self and nonself by the innate immune system. Science 296 (2002) 298-300
103. Mellado M., Rodriguez-Frade J.M., Vila-Coro A.J., Fernandez S., Martin de Ana A.M., Jones D.R., Toran J.L., and Martinez C. Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. Eur. Mol. Biol. Organ. J. 20 (2001) 2497-2507
104. Mellado M., Vila-Coro A.J., Martinez C., and Rodriguez-Frade J.M. Receptor dimerization: a key step in chemokine signaling. Cell. Mol. Biol. 47 (2001) 575-582
105. Meredith E.J., Chamba A., Holder M.J., Barnes N.M., and Gordon J. Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology 115 (2005) 289-295
106. Mulcahy L. The erythropoietin receptor. Semin. Oncol. 28 (2001) 19-23
107. Murphy J.E., Tedbury P.R., Homer-Vanniasinkam S., Walker J.H., and Ponnambalam S. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 182 (2005) 1-15
108. Nagatsu T., Mogi M., Ichinose H., and Togari A. Cytokines in Parkinson's disease. J. Neural Transm. Suppl. 58 (2000) 143-151
109. Nutt D.J. The role of dopamine and norepinephrine in depression and antidepressant treatment. J. Clin. Psychiatry 67 suppl. 6 (2006) 3-8
110. Olanow C.W., and Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22 (1999) 123-144
111. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjar A.M., Smith K.D., Wilson C.B., Schroeder L., and Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 13766-13771
112. Pacifi R., Pichini S., Zuccaro P., Farre M., Segura M., Ortuno J., Di Carlo S., Bacosi A., Roset P.N., Segura J., and De la Torre R. Paroxetine inhibits acute effects of 3,4-methylenedioxymethampetamine on the immune system in humans. J. Pharmacol. Exp. Ther. 309 1 (2003) 285-292
113. Percherancier Y., Berchiche Y.A., Slight I., Volkmer-Engert R., Tamamura H., Fujii N., Bouvier M., and Heveker N. Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J. Biol. Chem. 280 (2005) 9895-9903
114. Peters B., Sidney J., Bourne P., Bui H.-H., Buus S., Doh G., Fleri W., Kronenberg M., Kubo R., Lund O., Nemazee D., Ponomarenko J.V., and Sathiamurthy M. The design and implementation of the immune epitope database and analysis resource. Immunogenetics 57 (2005) 326-336
115. Premont R.T., and Gainetdinov R.R. Physiological roles of g protein-coupled receptor kinases and arrestins. Annu. Rev. Physiol. 69 (2007) 511-534
116. Prinster S.C., Hague C., and Hall R.A. Heterodimerization of G protein-coupled receptors: specificity and functional significance. Pharmacol. Rev. 57 3 (2005) 289-298
117. Proudfoot A.E.I. The biological relevance of chemokine-proteoglycan interactions. Biochem. Soc. Trans. 34 3 (2006) 422-426
118. Radchenko A.N. Transmembrane receptive dimers as molecular triggers having chemical and electrical inputs. Nucl. Instrum. Methods Phys. Res., Sect. A, Accel. Spectrom. Detect. Assoc. Equip. 502 (2003) 745-748
119. Rocheville M., Lange D.C., Kumar U., Patel S.C., Patel R.C., and Patel Y.C. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288 (2000) 154-157
120. Rodriguez-Frade J.M., Mellado M., and Martinez A.C. Chemokine receptor dimerization: two are better than one. Trends Immunol. 22 (2001) 612-617
121. Rodriguez-Frade J.M., del Real G., Serrano A., Hernanz-Falcon P., Soriano S.F., Vila-Coro A.J., Martin de Ana A.M., Lucas P., Prieto I., Martinez A.C., and Mellado M. Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor. Eur. Mol. Biol. Organ. J. 23 (2004) 66-76
122. Sadir R., Baleux F., Grosdidier A., Imberty A., and Lortat-Jacob H. Characterization of the stromal cell-derived factor-1alpha-heparin complex. J. Biol. Chem. 276 (2001) 8288-8296
123. Sakmar T.P. Structure of rhodopsin and the superfamily of seven-helical receptors: the same and not the same. Curr. Opin. Cell Biol. 14 (2002) 189-195
124. Sanudo-Pena M.C., and Walker J.M. A novel neurotransmitter system involved in the control of motor behavior by the basal ganglia. Ann. N.Y. Acad. Sci. 860 (1998) 475-479
125. Sanudo-Pena M.C., Tsou K., Romero J., Mackie K., and Walker J.M. Role of the superior colliculus in the motor effects of cannabinoids and dopamine. Brain Res. 853 (2000) 207-214
126. Sarkar C., Das S., Chakroborty D., Chowdhury U.R., Basu B., Dasgupta P.S., and Basu S. Stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Kruppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation. J. Immunol. 177 11 (2006) 7525-7529
127. Santambrogio L., Lipartiti M., Bruni A., and Dal Torso R. Dopamine receptors on human T and B lymphocytes. Neuroimmunology 45 (1993) 113-120
128. Sharp P., and Smith G. Cannabis: time for scientific evaluation of this ancient remedy?. Anesth. Analg. 90 (2000) 237-240
129. Shaw A.S., and Allen P.M. Kissing cousins: immunological and neurological synapses. Nat. Immunol. 2 7 (2001) 575-576
130. Shi C., Zhang X., Chen Z., Robinson M.K., and Simon D.I. Leukocyte integrin Mac-1 recruits Toll/Interleukin-1 receptor superfamily signaling intermediates to modulate NF-kB activity. Circ. Res. 89 10 (2001) 859-865
131. Shiepers O.J.G., Wichers M.C., and Maes M. Cytokines and major depression. Progress Neuro-Psychopharm. Biol. Psychiatry 29 (2005) 201-217
132. Sourjik V., and Berg H.C. Functional interactions between receptors in bacterial chemotaxis. Nature 428 (2004) 437-441
133. Stomski F.C., Sun Q., Bagley C.J., Woodcock J., Goodall G., Andrews R.K., Berndt M.C., and Lopez A.F. Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding. Mol. Cell. Biol. 16 6 (1996) 3035-3046
134. Stumm R.K., Rummel J., Junker V., Culmsee C., Pfeiffer M., Krieglstein J., Hollt V., and Schulz S. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J. Neurosci. 22 14 (2002) 5865-5878
135. Sugawa M., Sakurai Y., Ishikawa-Ieda Y., Suzuki H., and Asou H. Effects of erythropoietin on glial cell development: oligodendrocyte maturation and astrocyte proliferation. Neurosci. Res. 44 (2002) 391-403
136. Suzuki S., Chuang L.F., Yau P., Doi R.H., and Chuang R.Y. Interaction of opioid and chemokine receptors: oligomerization of mu, kappa and delta with CCR5 on immune cells. Exp. Cell Res. 280 (2002) 192-200
137. Takeda S., Kadowaki S., Haga T., Takaesu H., and Mitaku S. Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett. 520 (2002) 97-101
138. Terrillon S., and Bouvier M. Receptor activity-independent recruitment of barrestin-2 reveals specific signalling modes. EMBO J. 23 (2004) 3950-3961
139. Terrillon S., and Bouvier M. Roles of G-protein-coupled receptor dimerization: from ontogeny to signalling regulation. EMBO Rep. 5 1 (2004) 30-34
140. Toth P.T., Ren D., and Miller R.J. Regulation of CXXR4 receptor dimerization by the chemokine SDF-1alpha and the HIV-1 coat protein gp120: a fluorescence resonance energy transfer (FRET) study. J. Pharmacol. Exp. Ther. 310 (2004) 8-17
141. Trautmann A., and Vivier E. Agrin - a bridge between the nervous and immune systems. Science 292 5522 (2001) 1667-1668
142. Treanor B., Lanigan P.M.P., Kumar S., Dunsby C., Munro I., Auksorius E., Culley F.J., Purbhoo M.A., Phillips D., Neil M.A.A., Burshtyn D.N., French P.M.W., and Davis D.M. Microclusters of inhibitory killer immunoglobulin-like receptor signaling at natural killer cell immunological synapses. J. Cell Biol. 174 1 (2006) 153-161
143. Uings I.J., and Farrow S.N. J. Clin. Pathol. Mol Pathol. 53 (2000) 295-299
144. Ullrich A., and Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 61 2 (1990) 203-212
145. Ullrich O., and Shneider-Stock R. Endogenous cannabinoids-a local message in and between the nervous and immune system. Signal Transduc. 1/2 (2005) 19-27
146. Veldkamp C.T., Peterson F.C., Pelzek A.J., and Volkman B.F. The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin. Protein Sci. 14 (2005) 1071-1081
147. Vila M., Jackson-Lewis V., Guegan C., Wu D.C., Teismann P., Choi D.K., Tieu K., and Przedborski S. The role of glial cells in Parkinson's disease. Curr. Opin. Neurol. 14 (2001) 483-489
148. Vila-Coro A.J., Rodriguez-Frade J.M., Martin de Ana A., Moreno-Ortiz M.C., Martinez A.C., and Mellado M. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 13 (1999) 1699-1710
149. Watowich S.S., Hilton D.J., and Lodish H.F. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol. Cell. Biol. 14 (1994) 3535-3549
150. Wells T.N., Proudfoot A.E., and Power C.A. Chemokine receptors and their role in leukocyte activation. Immunol. Lett. 65 (1999) 35-40
151. Werry T.D., Wilkinson G.F., and Willars G.B. Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+. Biochem. J. 374 (2003) 281-296
152. Wrona D. Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. J. Neuroimmunol. 172 1-2 (2006) 38-58
153. Yoshioka K., Saitoh O., and Nakata H. Heteromeric association creates a P2Y-like adenosine receptor. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 7617-7622
154. Yu T.W., and Bargmann C.I. Dynamic regulation of axon guidance. Nat. Neurosci. 4 (2001) 1169-1176
155. Yu E.W., and Koshland Jr. D.E. Propagating conformational changes over long (and short) distances in proteins. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 9517-9520
156. Zhang K., McQuibban G.A., Silva C., Butler G.S., Johmson J.B., Holden J., Clark-Lewis I., Overall C.M., and Power C. HIV-induced metallo-proteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat. Neurosci. 6 (2003) 1064-1071
157. Zhang J., Wang Y., Chu Y., Su L., Gong Y., Zhang R., and Xiong S. Agrin is involved in lymphocytes activation that is mediated by alpha-dystroglycan. FASEB J. 20 (2006) 50-58
158. Zhang Y., DeVries M.E., and Skolnick J. Structure modeling of all identified G protein-coupled receptors in the human genome. PloS Comput. Biol. 2 2 (2006) 88-99
159. Zoli M., Agnati L.F., Hedlund P.B., Li X.M., Ferre S., and Fuxe K. Receptor-receptor interactions as an integrative mechanism in nerve cells. Mol. Neurobiol. 7 3-4 (1993) 293-334